Solventum Corp reported $670M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Align Technology USD 229.14M 31.74M Mar/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Cencora USD 1.41B 207.69M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Insulet USD 199.8M 18.1M Jun/2026
Solventum Corp USD 670M 233M Jun/2026
West Pharmaceutical Services USD 243.6M 17.4M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026